{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:14Z","timestamp":1791644654719,"version":"4.3.4"},"reference-count":26,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: The prevalence of Human Papilloma Virus (HPV) in T\u00fcrkiye may vary from that reported in other countries. Determining the age-specific distribution of HPV infection and its overall prevalence in all tested individuals, supported by a large sample size, would provide valuable insights for HPV prevention programs. This study aims to determine the regional prevalence of HPV infection. Methods: This is a retrospective study containing data from 52,930 patients who underwent HPV testing at a tertiary hospital between 2016 and 2024. Patients aged 21 to 65 were included in the study. Target DNA amplification by polymerase chain reaction (PCR) and nucleic acid hybridization techniques were performed for the identification of HPV. Overall prevalence, age-specific prevalence, and genotype distribution were examined. Results: Analysis of genotype distribution revealed that isolated HPV16 positivity was 4.0% (n = 2118), isolated HPV18 positivity was 1.0% (n = 528), and isolated other high-risk (HR) HPV types (excluding HPV16 and HPV18) were detected in 10.8% (n = 5693) of patients. The co-positivity rates were as follows: HPV16 and HPV18 in 0.4% (n = 237), HPV16 and HR-HPV other in 2.3% (n = 1197), HPV18 and HR-HPV other in 1.0% (n = 513), and HPV16, HPV18, and HR-HPV other in 0.3% (n = 145). Conclusions: This study highlights that HPV positivity is higher among individuals aged 21\u201324 years in our population, the overall prevalence is broadly consistent with the range reported in previous Turkish and international studies, and the pooled other HR-HPV group was more frequent than HPV16 or HPV18 individually.<\/jats:p>","DOI":"10.3390\/jcm15166323","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:26Z","timestamp":1786968086000},"page":"6323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Prevalence of Human Papilloma Virus in Turkish Women"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6394-3638","authenticated-orcid":false,"given":"G\u00f6kt\u00fcrk Han","family":"Do\u011fan","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology, \u0130zmir Tepecik Training and Research Hospital, 35100 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6013-6602","authenticated-orcid":false,"given":"Ceren","family":"Sa\u011flam Purut","sequence":"additional","affiliation":[{"name":"Department of Perinatology, \u0130zmir Atat\u00fcrk Training and Research Hospital, 35360 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-0935","authenticated-orcid":false,"given":"\u0130brahim","family":"G\u00fclhan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u0130zmir Tepecik Training and Research Hospital, 35100 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7308-352X","authenticated-orcid":false,"given":"\u0130layda","family":"Gercik Arz\u0131k","sequence":"additional","affiliation":[{"name":"Department of Perinatology, \u0130zmir City Hospital, 35540 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-3955","authenticated-orcid":false,"given":"Abdurrahman Hamdi","family":"\u0130nan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u0130zmir Tepecik Training and Research Hospital, 35100 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Sanc\u0131","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, \u0130zmir City Hospital, 35540 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeysa Nur","family":"\u00c7a\u011f\u0131ran","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u0130zmir Tepecik Training and Research Hospital, 35100 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus Emre","family":"Purut","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, \u0130zmir Tepecik Training and Research Hospital, 35100 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus-attributable cancers\u2014United States, 2012\u20132016","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12985-023-02221-w","article-title":"Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: A cross-sectional study of 3674 women from 2019 to 2022","volume":"20","author":"Zeng","year":"2023","journal-title":"Virol. J."},{"key":"ref_3","unstructured":"International Agency for Research on Cancer (IARC) (2012). Biological Agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100B, International Agency for Research on Cancer."},{"key":"ref_4","first-page":"363","article-title":"Prevalence and distribution of selected cervical human papillomavirus types in HIV infected and HIV uninfected women in South Africa, 1989\u20132021: A narrative review","volume":"37","author":"Rikhotso","year":"2022","journal-title":"S. Afr. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pvr.2019.03.002","article-title":"Mega HPV laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey","volume":"7","author":"Gultekin","year":"2019","journal-title":"Papillomavirus Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Luo, L.P., He, P., Liu, Q.T., Jiang, Y.H., Zhang, Y.N., Li, Q.Z., Li, Q., Li, S.T., Yang, F., and Ling, H. (2021). Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012\u20132018: Baseline measures prior to mass HPV vaccination. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06019-5"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Seyoum, A., Assefa, N., Gure, T., Seyoum, B., Mulu, A., and Mihret, A. (2022). Prevalence and genotype distribution of high-risk human papillomavirus infection among Sub-Saharan African women: A systematic review and meta-analysis. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.890880"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020\u201399: A modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23973","DOI":"10.1038\/s41598-024-74588-x","article-title":"The prevalence of HPV in Chongqing, China from 2017 to 2022: A retrospective cohort study","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2018.11.075","article-title":"Age-specific HPV prevalence among 116,052 women in Australia\u2019s renewed cervical screening program: A new tool for monitoring vaccine impact","volume":"37","author":"Brotherton","year":"2019","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis","volume":"7","author":"Diaz","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.34172\/aim.2023.64","article-title":"Prevalence of human papillomavirus (HPV) genotypes among women during 2015\u20132020 in Mashhad, Iran","volume":"26","author":"Bakhshani","year":"2023","journal-title":"Arch. Iran. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"H59","DOI":"10.1016\/j.vaccine.2013.03.029","article-title":"Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe","volume":"31","author":"Poljak","year":"2013","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1525-1438.2007.00944.x","article-title":"The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women","volume":"17","author":"Inal","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_16","first-page":"157","article-title":"Human papillomavirus frequency of women at low risk of developing cervical cancer: A preliminary study from a Turkish university hospital","volume":"24","author":"Ozcelik","year":"2003","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.31557\/APJCP.2022.23.7.2477","article-title":"Genotype distribution and prevalence of high-risk human papillomavirus infection among women in Samsun Province of Turkey","volume":"23","author":"Taskin","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_18","first-page":"e52615","article-title":"Human papillomavirus infection (HPV) prevalence in the Black Sea region of Turkey: Primary HPV screening for cervical cancer","volume":"16","author":"Dura","year":"2024","journal-title":"Cureus"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1002\/jmv.27921","article-title":"The prevalence and distribution of human papillomavirus in 4267 Turkish women with or without cervical lesions: A hospital-based study","volume":"94","author":"Kazanci","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/ijc.31212","article-title":"Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women","volume":"142","author":"Gultekin","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"Clifford","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jmv.21347","article-title":"Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy","volume":"81","author":"Agarossi","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00007435-199607000-00013","article-title":"Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors","volume":"23","author":"Burk","year":"1996","journal-title":"Sex. Transm. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e39495","DOI":"10.1097\/MD.0000000000039495","article-title":"Assessment of health literacy and HPV knowledge among university students: An observational study","volume":"103","author":"Kayak","year":"2024","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7314\/APJCP.2016.17.1.299","article-title":"Knowledge and attitudes of medical and non-medical Turkish university students about cervical cancer and HPV vaccination","volume":"17","author":"Borlu","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijc.33189","article-title":"The European response to the WHO call to eliminate cervical cancer as a public health problem","volume":"148","author":"Arbyn","year":"2021","journal-title":"Int. J. Cancer"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:26:26Z","timestamp":1786969586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":26,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166323"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166323","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}